Skip to main content

Table 1 included studies and patients’ characteristics. AS: aortic stenosis; HCM: hypertrophic cardiomyopathy; DCM: dilated cardiomyopathy; MR: mitral regurgitation; ARVD: arrhythmogenic right ventricular dysplasia; HFpEF: heart failure with preserved ejection fraction; HFrEF: heart failure with reduced ejection fraction; ICM: ischemic cardiomyopathy

From: Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis

Year

Author

Journal

Number of patients

Field

Disease type

Scan

2010

F.A.S [28]

circulation

26

1.5 T

AS(18) HCM (8)

EQ-CMR

2012

WSK [27]

JCMR

12

1.5 T

AS (12)

shMOLLI

2012

FM [26]

JCMR

18

1.5 T

AS(18)

shMOLLI

2013

WSK [24]

JACC

18

1.5 T

AS (18)

shMOLLI

2013

MCA [22]

Circulation

6

1.5 T

DCM(3) ischemia (3);

MOLLI

2014

ADSP [37]

JCMR

24

1.5 T

DCM(24)

MOLLI

2015

GY [20]

JCMR

20

3 T

DCM (20)

MOLLI

2015

DMDRC [21]

JCMR

31

3 T

SAS (12),severe aortic regurgitation (9),MR (10)

MOLLI

2015

KA [35]

JCMR

36

1.5 T

heart failure (HFpEF (22), cardiac amyloidosis (7), HFrEF (3), MR (4))

MOLLI

2015

LG [38]

JCMR

4

1.5 T

AS (4)

MOLLI

2016

KA [39]

JACC

36

1.5 T

heart failure (28), valvular heart disease (8)

MOLLI

2013

MJ [23]

Circulation

9

1.5 T

HFpEF (9)

FLASH

2008

IL [25]

JACC

9

1.5 T

heart transplantation recipients (9)

FLASH

2015

IL [40]

EHJ

12

1.5 T

HCM(8), DCM (2) ICM(1),restrictive(1)

FLASH

2012

SCT [41]

Radiology

47

1.5 T

DCM(13), myocarditis (11), infiltrative /restrictive cardiomyopathy(22),suspected ARVD (1)

Look-Locker